Jon E. Grant to Treatment Outcome
This is a "connection" page, showing publications Jon E. Grant has written about Treatment Outcome.
Connection Strength
1.995
-
A familial subtype of gambling disorder. J Behav Addict. 2024 Oct 04; 13(3):761-767.
Score: 0.098
-
Lifetime alcohol use disorder and gambling disorder: clinical profile and treatment response. CNS Spectr. 2024 Aug; 29(4):273-278.
Score: 0.097
-
Silymarin (Milk Thistle) Treatment of Adults With Gambling Disorder: A Double-Blind, Placebo-Controlled Trial. Clin Neuropharmacol. 2024 Mar-Apr 01; 47(2):54-58.
Score: 0.095
-
Time to Reconsider Monoamine Oxidase Inhibitors for Obsessive Compulsive Disorder?: A Case Series Using Phenelzine. J Clin Psychopharmacol. 2021 Jul-Aug 01; 41(4):461-464.
Score: 0.079
-
A double-blind, placebo-controlled study of vortioxetine in the treatment of binge-eating disorder. Int J Eat Disord. 2019 07; 52(7):786-794.
Score: 0.068
-
Efficacy of Pharmacological Interventions in Targeting Decision-Making Impairments across Substance and Behavioral Addictions. Neuropsychol Rev. 2019 03; 29(1):93-102.
Score: 0.068
-
Milk Thistle Treatment for Children and Adults with Trichotillomania: A Double-Blind, Placebo-Controlled, Crossover Negative Study. J Clin Psychopharmacol. 2019 Mar/Apr; 39(2):129-134.
Score: 0.067
-
Placebo response in trichotillomania. Int Clin Psychopharmacol. 2017 11; 32(6):350-355.
Score: 0.062
-
Double-blind switch study of vilazodone in the treatment of major depressive disorder. Int Clin Psychopharmacol. 2017 05; 32(3):121-126.
Score: 0.059
-
Refractory OCD Due to Thalamic Infarct With Response to Dronabinol. J Neuropsychiatry Clin Neurosci. 2017; 29(1):77-78.
Score: 0.057
-
Silymarin treatment of obsessive-compulsive spectrum disorders. J Clin Psychopharmacol. 2015 Jun; 35(3):340-2.
Score: 0.052
-
A single-blind study of 'as-needed' ecopipam for gambling disorder. Ann Clin Psychiatry. 2014 Aug; 26(3):179-86.
Score: 0.049
-
The opiate antagonist, naltrexone, in the treatment of trichotillomania: results of a double-blind, placebo-controlled study. J Clin Psychopharmacol. 2014 Feb; 34(1):134-8.
Score: 0.047
-
A randomized, placebo-controlled trial of N-acetylcysteine plus imaginal desensitization for nicotine-dependent pathological gamblers. J Clin Psychiatry. 2014 Jan; 75(1):39-45.
Score: 0.047
-
A proof of concept study of tolcapone for pathological gambling: relationships with COMT genotype and brain activation. Eur Neuropsychopharmacol. 2013 Nov; 23(11):1587-96.
Score: 0.046
-
Neurobiological considerations in understanding behavioral treatments for pathological gambling. Psychol Addict Behav. 2013 Jun; 27(2):380-92.
Score: 0.045
-
The relationship of tobacco use with gambling problem severity and gambling treatment outcome. Psychol Addict Behav. 2013 Sep; 27(3):696-704.
Score: 0.043
-
Open-label pilot study of memantine in the treatment of compulsive buying. Ann Clin Psychiatry. 2012 May; 24(2):119-26.
Score: 0.042
-
Neurocognitive response to deep brain stimulation for obsessive-compulsive disorder: a case report. Am J Psychiatry. 2011 Dec; 168(12):1338-9.
Score: 0.041
-
Dronabinol, a cannabinoid agonist, reduces hair pulling in trichotillomania: a pilot study. Psychopharmacology (Berl). 2011 Dec; 218(3):493-502.
Score: 0.039
-
A 6-month follow-up of imaginal desensitization plus motivational interviewing in the treatment of pathological gambling. Ann Clin Psychiatry. 2011 Feb; 23(1):3-10.
Score: 0.039
-
Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study. Br J Psychiatry. 2010 Oct; 197(4):330-1.
Score: 0.038
-
Memantine shows promise in reducing gambling severity and cognitive inflexibility in pathological gambling: a pilot study. Psychopharmacology (Berl). 2010 Dec; 212(4):603-12.
Score: 0.037
-
A double-blind, placebo-controlled trial of lamotrigine for pathological skin picking: treatment efficacy and neurocognitive predictors of response. J Clin Psychopharmacol. 2010 Aug; 30(4):396-403.
Score: 0.037
-
Imaginal desensitisation plus motivational interviewing for pathological gambling: randomised controlled trial. Br J Psychiatry. 2009 Sep; 195(3):266-7.
Score: 0.035
-
Pathologic gambling and bankruptcy. Compr Psychiatry. 2010 Mar-Apr; 51(2):115-20.
Score: 0.035
-
Predicting response to opiate antagonists and placebo in the treatment of pathological gambling. Psychopharmacology (Berl). 2008 Nov; 200(4):521-7.
Score: 0.032
-
Lamotrigine treatment of pathologic skin picking: an open-label study. J Clin Psychiatry. 2007 Sep; 68(9):1384-91.
Score: 0.030
-
N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study. Biol Psychiatry. 2007 Sep 15; 62(6):652-7.
Score: 0.030
-
N-acetyl cysteine in the treatment of grooming disorders. J Clin Psychopharmacol. 2007 Apr; 27(2):227-9.
Score: 0.030
-
Late-onset obsessive compulsive disorder: clinical characteristics and psychiatric comorbidity. Psychiatry Res. 2007 Jul 30; 152(1):21-7.
Score: 0.029
-
Addicted to hair pulling? How an alternate model of trichotillomania may improve treatment outcome. Harv Rev Psychiatry. 2007 Mar-Apr; 15(2):80-5.
Score: 0.029
-
Medication management of pathological gambling. Minn Med. 2006 Sep; 89(9):44-8.
Score: 0.028
-
Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry. 2006 Feb; 163(2):303-12.
Score: 0.027
-
Outcome study of kleptomania patients treated with naltrexone: a chart review. Clin Neuropharmacol. 2005 Jan-Feb; 28(1):11-4.
Score: 0.025
-
Increased apathy post-interstitial laser capsulotomy for refractory obsessive-compulsive disorder. J Neurol Neurosurg Psychiatry. 2024 Sep 17; 95(10):899-901.
Score: 0.025
-
Pharmacotherapy outcome in older pathological gamblers: a preliminary investigation. J Geriatr Psychiatry Neurol. 2004 Mar; 17(1):9-12.
Score: 0.024
-
Effectiveness of pharmacotherapy for pathological gambling: a chart review. Ann Clin Psychiatry. 2002 Sep; 14(3):155-61.
Score: 0.021
-
An open-label study of naltrexone in the treatment of kleptomania. J Clin Psychiatry. 2002 Apr; 63(4):349-56.
Score: 0.021
-
Adolescent kleptomania treated with naltrexone--a case report. Eur Child Adolesc Psychiatry. 2002 Apr; 11(2):92-5.
Score: 0.021
-
A case of kleptomania and compulsive sexual behavior treated with naltrexone. Ann Clin Psychiatry. 2001 Dec; 13(4):229-31.
Score: 0.020
-
Interstitial laser anterior capsulotomy for obsessive-compulsive disorder: lesion size and tractography correlate with outcome. J Neurol Neurosurg Psychiatry. 2022 03; 93(3):317-323.
Score: 0.020
-
Treatment of agitation and aggression in four demented patients using ECT. J ECT. 2001 Sep; 17(3):205-9.
Score: 0.020
-
An open naltrexone treatment study in pathological gambling disorder. Int Clin Psychopharmacol. 2001 Sep; 16(5):285-9.
Score: 0.020
-
The psychopharmacology of pathological gambling. Semin Clin Neuropsychiatry. 2001 Jul; 6(3):184-94.
Score: 0.020
-
Successful treatment of nondelusional body dysmorphic disorder with olanzapine: a case report. J Clin Psychiatry. 2001 Apr; 62(4):297-8.
Score: 0.019
-
Naltrexone improves quit rates, attenuates smoking urge, and reduces alcohol use in heavy drinking smokers attempting to quit smoking. Alcohol Clin Exp Res. 2014 Oct; 38(10):2622-9.
Score: 0.012
-
The effectiveness of a cognitive-behavioral intervention for pathological gambling: a country-wide study. Ann Clin Psychiatry. 2013 Nov; 25(4):250-6.
Score: 0.012
-
N-Acetylcysteine in the treatment of pediatric trichotillomania: a randomized, double-blind, placebo-controlled add-on trial. J Am Acad Child Adolesc Psychiatry. 2013 Mar; 52(3):231-40.
Score: 0.011
-
Effects of acute modafinil on cognition in trichotillomania. Psychopharmacology (Berl). 2010 Dec; 212(4):597-601.
Score: 0.009
-
Augmentation with naltrexone to treat compulsive sexual behavior: a case series. Ann Clin Psychiatry. 2010 Feb; 22(1):56-62.
Score: 0.009
-
A pilot study of impulsivity and compulsivity in pathological gambling. Psychiatry Res. 2009 May 15; 167(1-2):161-8.
Score: 0.008
-
Decreased memory loss associated with right unilateral ultra-brief pulse wave ECT. Minn Med. 2007 Jan; 90(1):34-5.
Score: 0.007
-
A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling. J Clin Psychiatry. 2002 Jun; 63(6):501-7.
Score: 0.005
-
Prospective evaluation of Roux-en-Y gastric bypass as primary operation for medically complicated obesity. Mayo Clin Proc. 2000 Jul; 75(7):673-80.
Score: 0.005